Publications by authors named "Thomas Jouary"

Claim this Profile
G
Genomic and clinical characterization of anogenital basal cell carcinoma: A retrospective and prospective cohort study.
Lea Dousset, Andrey A Yurchenko, Johan Chanal, Marie Beylot-Barry, Mahtab Samimi, Thomas Jouary

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety and reasons for discontinuation of sonidegib for patients with locally advanced basal cell carcinoma: A real-word evidence analysis from the French national registry CARADERM.
Nicole Basset-Seguin, Mourad Djermane, Florian Herms, Sophie Dalac, Olivier Dereure, Thomas Jouary

J Eur Acad Dermatol Venereol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi Consensus.
Gabriella Brancaccio, Giulia Briatico, Zoe Apalla, Reinhard Dummer, Jan Eklind, Thomas Jouary

Dermatol Pract Concept· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.
Robin Zagala, Stephane Dalle, Marie Beylot-Barry, Nicolas Meyer, Philippe Saiag, Thomas Jouary

J Eur Acad Dermatol Venereol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
Thibault Kervarrec, Danna Westphal, Daniel Pissaloux, Mélanie Legrand, Franck Tirode, Thomas Jouary

Histopathology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).
Perrine Rousset, Charlée Nardin, Eve Maubec, Valentine Heidelberger, Alexandra Picard, Thomas Jouary

Oncologist· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high-throughput sequencing approach.
Baptiste Louveau, Ines Nakouri, Fanélie Jouenne, Barouyr Baroudjian, Aurélie Sadoux, Thomas Jouary

Br J Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.
Thibault Kervarrec, Sandrine Imbeaud, David Veyer, Helene Pere, Julien Puech, Thomas Jouary

Am J Surg Pathol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey.
Thibault Kervarrec, Anne Tallet, Nicolas Macagno, Arnaud de la Fouchardière, Daniel Pissaloux, Thomas Jouary

Am J Surg Pathol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo, Elisa Funck-Brentano, Eve Puzenat, Thomas Jouary

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial.
Eggert Stockfleth, Thomas Jouary, Francesca Farnetani, Antonio Macaya Pascual, Cecilia De Almeida Agudo

Dermatol Ther (Heidelb)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Marie Véron, Sylvie Chevret, Jean-Jacques Grob, Marie Beylot-Barry, Philippe Saiag, Thomas Jouary

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vismodegib efficacy in unresectable trichoblastic carcinoma: A multicenter study of 16 cases.
Alexandra Duplaine, Marie Beylot-Barry, Sandrine Mansard, Jean-Philippe Arnault, Jean-Jacques Grob, Thomas Jouary

J Am Acad Dermatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma.
Thibault Kervarrec, Daniel Pissaloux, Jeremie Poilane, Franck Tirode, Anne Tallet, Thomas Jouary

J Pathol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.
Maxime Battistella, Brigitte Balme, Marie-Laure Jullie, Ute Zimmermann, Agnès Carlotti, Thomas Jouary

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.
Sandrine Monestier, Stéphane Dalle, Laurent Mortier, Caroline Dutriaux, Sophie Dalac-Rat, Thomas Jouary

Int J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.
Julie Delyon, Raphael Porcher, Maxime Battistella, Nicolas Meyer, Henri Adamski, Thomas Jouary

J Invest Dermatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-induced Bullous Lichen Planus: An Isomorphic Manifestation of Radiotherapy.
Paul Cirotteau, Philippine Lucas, Léa Dousset, Valérie Cales, Olivier Gilliot, Thomas Jouary

Acta Derm Venereol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.
Olivier Bouché, Meher Ben Abdelghani, Jean-Luc Labourey, Simon Triby, René-Jean Bensadoun, Thomas Jouary

World J Gastroenterol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Brigitte Dreno, John F Thompson, Bernard Mark Smithers, Mario Santinami, Thomas Jouary

Lancet Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.
Julie Delyon, Sylvie Chevret, Thomas Jouary, Sophie Dalac, Stephane Dalle

J Invest Dermatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes for patients with locally advanced basal cell carcinoma before availability of Hedgehog pathway inhibitors: a retrospective chart review.
John T Lear, Nicole Basset-Seguin, Martin Kaatz, Thomas Jouary, Laurent Mortier

Eur J Dermatol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
Anne-Sophie Darrigade, Brigitte Milpied, Marie-Elise Truchetet, Thierry Schaeverbeke, David Laharie, Thomas Jouary

Acta Derm Venereol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Guidelines for stage I to III melanoma].
Bernard Guillot, Sophie Dalac, Marc Denis, Alain Dupuy, Jean François Emile, Thomas Jouary

Bull Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
Camille Salzes, Sophie Abadie, Julien Seneschal, Maxine Whitton, Jean-Marie Meurant, Thomas Jouary

J Invest Dermatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis